This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street
Illumina Inc ILMN
$140.99
βΌ -0.37%
($-0.52)
Open
$142.00
Prev Close
$141.51
Day Range
$139.62 β $142.79
52W Range
$78.55 β $155.53
Market Cap
$21.41B
P/E (TTM)
25.02
Beta
1.42
EPS (TTM)
$5.52
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-06-28 |
| Shares Out. | 151,910,000 |
| Website | illumina.com β |
| Phone | 13026587581 |
Illumina Inc is a publicly traded company under the ticker symbol ILMN on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
28 analysts (2026-05-01)
π° Latest News for ILMN
1 Surging Stock on Our Buy List and 2 Facing Challenges
Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says
Cisco upgraded, Doximity downgraded: Wall Street's top analyst calls
Here Are Fridayβs Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More
RBC Capital Reinstates Outperform on Illumina, Announces $170 Price Target
Is Illumina (ILMN) Pricing Look Interesting After 77% One Year Share Price Gain
Nateraβs Stronghold in Cancer Recurrence Tests Prompts Woodβs Ark to Expand Stake
